Operating Expenses: The sum of all operating expenses for the given industry.
Enanta Pharmaceuticals, Inc. (ENTA) had Operating Expenses of $33.51M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$15.12M |
|
$-18.70M |
|
-- |
|
$15.12M |
|
|
Operating Expenses |
$33.51M |
$-18.39M |
|
$-0.28M |
|
$-18.67M |
|
$-18.67M |
|
$-18.70M |
|
$-18.70M |
|
$-18.70M |
|
$-18.70M |
|
$-18.39M |
|
$-18.06M |
|
21.34M |
|
21.34M |
|
$-0.88 |
|
$-0.88 |
|
| Balance Sheet Financials | |
$204.34M |
|
$35.40M |
|
$76.40M |
|
$280.73M |
|
$48.55M |
|
-- |
|
$167.46M |
|
$216.01M |
|
$64.72M |
|
$64.72M |
|
$64.72M |
|
21.39M |
|
| Cash Flow Statement Financials | |
$-19.27M |
|
$40.35M |
|
$-26.62M |
|
$41.20M |
|
$35.66M |
|
$-5.54M |
|
$18.57M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.21 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-121.56% |
|
-121.56% |
|
-- |
|
-123.42% |
|
-123.64% |
|
$-32.17M |
|
-- |
|
-- |
|
-- |
|
0.05 |
|
-- |
|
2.20 |
|
40.95 |
|
-28.89% |
|
-28.90% |
|
-6.66% |
|
-28.89% |
|
$3.03 |
|
$-1.51 |
|
$-0.90 |
|